Florio BPN project BPN-36938
Active Awarded Last action
- Contract number
- 75N95024F00001
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,502,592
Award facts
- Contract value 80% obligated
-
- $2,502,592.00 Current, with exercised options
- $3,140,340.00 Potential, with all options
- Completion date 35% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12203, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,412,999 | |
| Original award | $1,089,593 |
About this award
This is a delivery order award under the Drug Manufacturing and Formulation Program (DMFP) Indefinite Delivery/Indefinite Quantity (IDIQ) contract, which was awarded to Curia Global Inc. (doing business as Amri), a for-profit organization and manufacturer of goods. The award, valued at $3,140,340.00, is for the National Institute of Neurological Disorders and Stroke (NINDS), a civilian federal agency. The contract is a Cost Plus Fixed Fee type, with an ultimate completion date of September 16, 2030. The award was made on September 17, 2024, and there was no small business set-aside used. The contract is for drug manufacturing and formulation services, and Curia Global Inc. has demonstrated expertise in providing specialized pharmaceutical research and development support to various National Institutes of Health (NIH) components.
Quick answers
Who was awarded contract 75N95024F00001?
75N95024F00001 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 17, 2024.
How much is contract 75N95024F00001 worth?
The government has obligated $2,502,592 on 75N95024F00001. Its potential value, with all options, is $3,140,340.
Which agency awarded contract 75N95024F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024F00001, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95024F00001 an order under another contract?
Yes. 75N95024F00001 is a delivery order under HHSN271201500005I, an indefinite delivery contract, on Drug Manufacturing and Formulation Program (DMFP).
Was contract 75N95024F00001 competed?
The extent of competition for 75N95024F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award